OpioidHALT
Cross-source consensus on OpioidHALT from 1 sources and 5 claims.
1 sources · 5 claims
Uses
Where it comes from
Other
Other
Other
Highlighted claims
- OpioidHALT is a two-arm randomised clinical trial of pharmacist-partnered opioid tapering before elective THA or TKA compared with standard care. — Responsible preoperative opioid use for hip or knee arthroplasty (OpioidHALT): a protocol for a randomised clinical trial of pharmacist-partnered opioid tapering prior to hip or knee arthroplasty
- The trial's main clinical target is persistent opioid use 3 months after surgery. — Responsible preoperative opioid use for hip or knee arthroplasty (OpioidHALT): a protocol for a randomised clinical trial of pharmacist-partnered opioid tapering prior to hip or knee arthroplasty
- The planned sample size is 314 participants, split equally between intervention and control groups. — Responsible preoperative opioid use for hip or knee arthroplasty (OpioidHALT): a protocol for a randomised clinical trial of pharmacist-partnered opioid tapering prior to hip or knee arthroplasty
- The key secondary outcome is WOMAC-measured joint pain, stiffness and function 3 months after surgery. — Responsible preoperative opioid use for hip or knee arthroplasty (OpioidHALT): a protocol for a randomised clinical trial of pharmacist-partnered opioid tapering prior to hip or knee arthroplasty
- The study will recruit from public hospitals in multiple Australian states that offer elective THA or TKA. — Responsible preoperative opioid use for hip or knee arthroplasty (OpioidHALT): a protocol for a randomised clinical trial of pharmacist-partnered opioid tapering prior to hip or knee arthroplasty